Kopin (KOPN) Stock News

Kopin Corporation (NASDAQ: KOPN) and HMDmd have initiated production deliveries of their CR3 wearable surgical monitor to Carl Zeiss Meditec. The FDA-registered and CE-certified device is a head-mounted display system developed jointly by Kopin and HMDmd.

The CR3 system features full HD resolution with 3-D imagery capabilities, designed specifically for microsurgery, minimally invasive surgery, digital and robotic surgery, and interventional medicine. The lightweight device allows surgeons to view surgical instrument feeds and diagnostic images without constantly shifting focus between wall-mounted monitors and patients, improving ergonomics and operational efficiency.

Kopin Corporation (NASDAQ: KOPN), a provider of optical systems and microdisplays, has announced the implementation of its comprehensive Environmental, Social, and Governance (ESG) framework. The initiative focuses on five key pillars: board composition & governance, labor practices & human rights, business ethics & integrity, environmental impact management, and supply chain responsibility.

Under CEO Michael Murray's leadership, the company aims to foster long-term stakeholder value while reducing environmental impact. Key aspects include maintaining a diverse board, implementing comprehensive waste management systems, ensuring EPA compliance, and partnering with responsible suppliers.

Kopin Corporation (KOPN) will showcase its advanced spatial light modulators (SLMs) and microdisplays at Laser World of Photonics 2025 in Munich from June 24-27. The company will feature its high-resolution binary phase modulator with a 2048 x 2048 pixel array, designed for 3D metrology and Super Resolution Microscopy applications. The exhibition will highlight Kopin's LCD and OLED microdisplays for Near-Eye applications, along with a medical Head-Mounted Display specifically designed for surgeons, offering high-resolution 2D and 3D surgical viewing capabilities. The event provides an opportunity for Kopin to demonstrate its display solutions and connect with global innovators.

Kopin Corporation (KOPN) announces its Vision-Tech Roadshow from June 9-25, 2025, spanning San Francisco, LA/Long Beach, New York City, and Washington D.C. The roadshow will showcase live demonstrations of Kopin's near-to-eye AR/VR systems and innovative technologies. Key highlights include the AI-powered NeuralDisplay prototype that adapts to users' vision requirements, a medical headset for surgical procedures, military-focused solutions including a daytime visual augmentation system and night vision goggle clip-in solution, and advanced MicroLED displays. The event, requiring appointment-based attendance, demonstrates Kopin's commitment to advancing AR/VR technology across medical, defense, enterprise, and commercial applications.

Kopin Corporation (KOPN) has achieved significant milestones in developing its NeuralDisplay prototype, an AI-powered technology for AR/VR solutions. The technology eliminates dedicated eye-tracking cameras, reducing size, weight, power consumption, and cost. The hardware prototype, based on OLED technology with MicroLED compatibility, enables eye image capture and provides insights for custom optics development. Software advancements include automatic vergence adjustment and augmented reality rangefinder capabilities. The system can track user's gaze direction, pupil size, and eyeball in real-time, while enabling dynamic brightness and contrast adjustments, eye fatigue monitoring, and response to neurological stimuli. Kopin's next steps involve enhancing silicon architecture for improved color accuracy, brightness, and sensor sensitivity.

Kopin Corporation (KOPN) has announced the retirement of CFO Rich Sneider after 25 years of service. The company has initiated a search for his replacement, considering both internal and external candidates. Sneider will continue in his role until a successor is appointed and will assist in the transition process.

CEO Michael Murray acknowledged Sneider's significant contributions, noting his role in Kopin's evolution from a technology-focused company to one commercializing application-specific optical solutions across various industries. Kopin specializes in optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer, and medical products.

Kopin Corporation (NASDAQ: KOPN), a provider of optical systems and microdisplays, will be added to the Russell 2000® and Russell 3000® Indexes following the 2025 Russell indexes reconstitution. The inclusion will become effective on June 27, 2025. This addition signifies Kopin's growing market presence and automatically includes the company in related growth and value style indexes.

The Russell indexes, which benchmark approximately $10.6 trillion in assets, are widely used by investment managers and institutional investors. FTSE Russell determines index membership primarily through market capitalization rankings and style attributes. The company will transition to semi-annual reconstitution frequency starting from 2026 to maintain accurate market representation.

Kopin Corporation (KOPN) reported its Q1 2025 financial results, showing positive momentum in both revenue and operational efficiency. Total revenues reached $10.5 million, up 5% from Q1 2024, with product revenues increasing 2% and funded research revenues growing 37%. The company received approximately $28 million in orders, achieving a strong 2.8:1 book-to-bill ratio. Cost of Product Revenues improved to 83% of net product revenues, down from 95% in Q1 2024. The company reported a net loss of $3.1 million ($0.02 per share), significantly better than the $32.5 million loss in Q1 2024. Notable orders included contracts for thermal weapons sights and pilot Helmet Mounted Display Systems. Kopin reaffirmed expectations for double-digit revenue growth in 2025 and is implementing an automation plan to enhance quality and improve margins.

Kopin Corporation (NASDAQ: KOPN), a provider of optical systems and microdisplays for defense, training, enterprise, industrial, consumer and medical products, has scheduled its first quarter 2025 earnings conference call for Tuesday, May 13, 2025, at 5:00 PM ET. The company will release its financial results for Q1 2025 (ended March 29, 2025) via press release before the call.

Participants can join via phone using U.S. dial-in (800-445-7795) or international number (785-424-1699) with Conference ID: KOPIN. A webcast option is also available through Kopin's investor relations website. A replay will be accessible through May 20, 2025.